Rabbit anti-Human ASAP3 Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-02440A
Western blot  | All lanes: ASAP3 antibody at 1µg/ml  | Lane 1: A549 whole cell lysate  | Lane 2: MCF-7 whole cell lysate  | Lane 3: K562 whole cell lysate  | Secondary  | Goat polyclonal to rabbit IgG at 1/10000 dilution  | Predicted band size: 100, 44, 98 kDa  | Observed band size: 100 kDa
Western blot | All lanes: ASAP3 antibody at 1µg/ml | Lane 1: A549 whole cell lysate | Lane 2: MCF-7 whole cell lysate | Lane 3: K562 whole cell lysate | Secondary | Goat polyclonal to rabbit IgG at 1/10000 dilution | Predicted band size: 100, 44, 98 kDa | Observed band size: 100 kDa
Immunohistochemistry of paraffin-embedded human liver cancer using ASAP3 Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human liver cancer using ASAP3 Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human skeletal muscle tissue using ASAP3 Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human skeletal muscle tissue using ASAP3 Antibody at dilution of 1:100

Rabbit anti-Human ASAP3 Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-02440A
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.

Product Overview

Product Title Rabbit anti-Human ASAP3 Polyclonal Antibody
Description The antibody against ASAP3 was raised in rabbit using the Recombinant Human Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 protein (451-700AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.
Uniprot Id - Alink Q8TDY4
Host Species Rabbit
Reactivity Human
Target Name ASAP3
Target Synonyms 9430088F20Rik antibody; ACAP4 antibody; ANK repeat and PH domain-containing protein 3 antibody; Arf GAP with SH3 domain antibody; Arf GAP with SH3 domain; ANK repeat and PH domain containing protein 3 antibody; Arf-GAP with SH3 domain antibody; ARF6 GTPase activating protein antibody; ArfGAP with SH3 domain; ankyrin repeat and PH domain antibody; ArfGAP with SH3 domain; ankyrin repeat and PH domain 3 1 antibody; ASAP3 antibody; ASAP3_HUMAN antibody; BOS_2358 antibody; Centaurin; beta 6 antibody; CENTB6 antibody; DDEFL1 antibody; Development and differentiation enhancing factor like 1 antibody; Development and differentiation-enhancing factor-like 1 antibody; FLJ20199 antibody; Gm140 antibody; MGC102639 antibody; MGC155101 antibody; OTTMUSP00000010435 antibody; Protein up-regulated in liver cancer 1 antibody; RP23-118A9.4 antibody; Up regulated in liver cancer 1 (UPLC1) antibody; UPLC1 antibody
Immunogen Description Recombinant Human Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 protein (451-700AA)
Immunogen Species Human
Immunogen Sequence Complete sequences for the immunogen, target protein, and peptides are available upon request.
Conjugate Non-conjugated
Clonality Polyclonal
Isotype IgG
Purification Method Antigen affinity purified
Buffer 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form Liquid
Application ELISA, WB, IHC
Storage Conditions Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

FAQs

Please fill out the Online Inquiry form located on the product page. Key product information has been pre-populated. You may also email your questions and inquiry requests to sales1@betalifesci.com. We will do our best to get back to you within 4 business hours.

Feel free to use the Chat function to initiate a live chat. Our customer representative can provide you with a quote immediately.

Proteins are sensitive to heat, and freeze-drying can preserve the activity of the majority of proteins. It improves protein stability, extends storage time, and reduces shipping costs. However, freeze-drying can also lead to the loss of the active portion of the protein and cause aggregation and denaturation issues. Nonetheless, these adverse effects can be minimized by incorporating protective agents such as stabilizers, additives, and excipients, and by carefully controlling various lyophilization conditions.

Commonly used protectant include saccharides, polyols, polymers, surfactants, some proteins and amino acids etc. We usually add 8% (mass ratio by volume) of trehalose and mannitol as lyoprotectant. Trehalose can significantly prevent the alter of the protein secondary structure, the extension and aggregation of proteins during freeze-drying process; mannitol is also a universal applied protectant and fillers, which can reduce the aggregation of certain proteins after lyophilization.

Our protein products do not contain carrier protein or other additives (such as bovine serum albumin (BSA), human serum albumin (HSA) and sucrose, etc., and when lyophilized with the solution with the lowest salt content, they often cannot form A white grid structure, but a small amount of protein is deposited in the tube during the freeze-drying process, forming a thin or invisible transparent protein layer.

Reminder: Before opening the tube cap, we recommend that you quickly centrifuge for 20-30 seconds in a small centrifuge, so that the protein attached to the tube cap or the tube wall can be aggregated at the bottom of the tube. Our quality control procedures ensure that each tube contains the correct amount of protein, and although sometimes you can't see the protein powder, the amount of protein in the tube is still very precise.

To learn more about how to properly dissolve the lyophilized recombinant protein, please visit Lyophilization FAQs.

Recently viewed